Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits

被引:32
作者
Hashizoe, M
Ogura, Y
Takanashi, T
Kunou, N
Honda, Y
Ikada, Y
机构
[1] KYOTO UNIV,FAC MED,DEPT OPTOMETRY & VISUAL SCI,SAKYO KU,KYOTO 606,JAPAN
[2] KYOTO UNIV,BIOMED ENGN RES CTR,SAKYO KU,KYOTO 606,JAPAN
关键词
AIDS; cytomegalovirus retinitis; ganciclovir; sustained drug release; polymeric device;
D O I
10.1076/ceyr.16.7.633.5063
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
Purpose. A scleral plug made of biodegradable polymer implanted at the pars plana was evaluated to determine its ability to control the intravitreal release of ganciclovir. Methods. Scleral plugs containing 25% ganciclovir were prepared with poly(lactic-glycolic acid) (molecular weight, 121 kDa). The release of ganciclovir was evaluated in vitro by spectrophotometry. in vivo intravitreal ganciclovir concentrations were measured by high performance liquid chromatography following plug implantation in pigmented rabbits. The biocompatibility of the device was determined by indirect ophthalmoscopy, electroretinography, and light and electron microscopy. Results. The in vitro study showed that the plug released ganciclovir throughout a 10-week period. The in vivo study demonstrated that the plugs maintained the drug concentration in the vitreous in a therapeutic range adequate to treat cytomegalovirus (CMV) retinitis for 12 weeks. No significant retinal toxicity was observed. Conclusions. This study demonstrated that this drug delivery system can potentially be useful to treat CMV retinitis.
引用
收藏
页码:633 / 639
页数:7
相关论文
共 35 条
[1]   CONTROL OF CYTOMEGALOVIRUS RETINITIS USING SUSTAINED-RELEASE OF INTRAOCULAR GANCICLOVIR [J].
ANAND, R ;
NIGHTINGALE, SD ;
FISH, RH ;
SMITH, TJ ;
ASHTON, P .
ARCHIVES OF OPHTHALMOLOGY, 1993, 111 (02) :223-227
[2]   TREATMENT OF CYTOMEGALO-VIRUS RETINITIS WITH INTRAVITREAL GANCICLOVIR - LONG-TERM RESULTS [J].
CANTRILL, HL ;
HENRY, K ;
MELROE, NH ;
KNOBLOCH, WH ;
RAMSAY, RC ;
BALFOUR, HH .
OPHTHALMOLOGY, 1989, 96 (03) :367-374
[3]  
COCHEREAUMASSIN I, 1991, OPHTHALMOLOGY, V98, P1348
[4]   A PROSPECTIVE-STUDY OF THE OPHTHALMOLOGIC FINDINGS IN THE ACQUIRED IMMUNE-DEFICIENCY SYNDROME [J].
FREEMAN, WR ;
LERNER, CW ;
MINES, JA ;
LASH, RS ;
NADEL, AJ ;
STARR, MB ;
TAPPER, ML .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1984, 97 (02) :133-142
[5]  
GROSS JG, 1990, OPHTHALMOLOGY, V97, P681
[6]   SCLERAL PLUG OF BIODEGRADABLE POLYMERS FOR CONTROLLED DRUG-RELEASE IN THE VITREOUS [J].
HASHIZOE, M ;
OGURA, Y ;
KIMURA, H ;
MORITERA, T ;
HONDA, Y ;
KYO, M ;
HYON, SH ;
IKADA, Y .
ARCHIVES OF OPHTHALMOLOGY, 1994, 112 (10) :1380-1384
[7]   IMPLANTABLE BIODEGRADABLE POLYMERIC DEVICE IN THE TREATMENT OF EXPERIMENTAL PROLIFERATIVE VITREORETINOPATHY [J].
HASHIZOE, M ;
OGURA, Y ;
TAKANASHI, T ;
KUNOU, N ;
HONDA, Y ;
IKADA, Y .
CURRENT EYE RESEARCH, 1995, 14 (06) :473-477
[8]   LONG-TERM INTRAVITREAL GANCICLOVIR THERAPY FOR CYTOMEGALO-VIRUS RETINOPATHY [J].
HEINEMANN, MH .
ARCHIVES OF OPHTHALMOLOGY, 1989, 107 (12) :1767-1772
[9]  
HENDERLY DE, 1987, OPHTHALMOLOGY, V94, P425
[10]   USE OF INTRAVITREAL GANCICLOVIR (DIHYDROXY PROPOXYMETHYL GUANINE) FOR CYTOMEGALOVIRUS RETINITIS IN A PATIENT WITH AIDS [J].
HENRY, K ;
CANTRILL, H ;
FLETCHER, C ;
CHINNOCK, BJ ;
BALFOUR, HH .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1987, 103 (01) :17-23